Drug Trial Radar · NCT06909162
A Study to Evaluate the Effect of Food on the Single-Dose Pharmacokinetics and a Drug-Drug Interaction Evaluation of Itraconazole and Carbamazepine on INCB123667 When Administered Orally to Healthy Adult Participants
Last checked: Nov 20, 2026Latest source record: Jun 15, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
51
Actual
Start
May 5, 2025
Primary completion
May 17, 2026
Study completion May 17, 2026
Sponsor
- Lead sponsor
- Incyte CorporationIncyte (INCY)
- Sponsor type
- Industry
- First posted
- Apr 3, 2025
Design
- Study type
- Interventional
- Phase
- Phase 1
- Allocation
- Randomized
- Model
- Crossover
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 19 years, up to 55 years
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
This study will be conducted to evaluate the effect of food on the single-dose pharmacokinetics and a drug-drug interaction evaluation of itraconazole and carbamazepine on INCB123667 when administered orally to healthy adult participants.
Conditions
- Healthy Participants
Interventions
INCB123667Drug
single dose administered orally
itraconazoleDrug
Oral: Tablet
carbamazepineDrug
Oral; Tablet
Primary outcomes
What the sponsor says the trial is designed to measure.
- Pharmacokinetics Parameter (PK): Cmax of INCB123667Time frame: Up to Day 16
- Pharmacokinetics Parameter: Tmax of INCB123667Time frame: Up to Day 16
- Pharmacokinetics Parameter: AUCt of INCB123667Time frame: Up to Day 16
- Pharmacokinetics Parameter: AUC∞ of INCB123667Time frame: Up to Day 16
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Celerion, Inc
Lincoln, Nebraska
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.